• About Us
  • Subscribe
  • Podcast
  • Earn CE
  • Free Samples
    1. Practice Management
    2. Industry

    National Dentex Corporation announces extension of exclusive agreement for the NTI-tss

    April 30, 2008
    Contract runs through 2023.

    NATICK, Massachusetts--National Dentex Corporation, one of the largest owner/operators of dental laboratories in North America, has announced that it has extended an agreement for exclusive manufacturing and distribution rights to fabricate and market the lab version of the NTI-tss.

    The contract runs through 2023 and also grants exclusive use of the trademarked name.

    The NTI-tss, a small, custom-made dental mouthpiece, is FDA approved for the prevention and treatment of migraine pain. The product name refers to nighttime tension suppression system.

    The device offers an affordable, non-pharmaceutical option to an estimated 28 million Americans suffering from various forms of migraine headache.

    In clinical trials reviewed by the FDA in 2001, 82% of medically diagnosed migraine sufferers using the NTI-tss had a 77% average reduction of migraine pain attacks within the first eight weeks of use. Successful outcomes are produced by reducing head, neck and jaw muscle contraction intensity by nearly 70%.

    The NTI-tss device was developed and patented by entrepreneurial dentist, James Boyd, DDS. Having suffered chronic, all-day headaches and frequent migraine attacks for 12 years, Dr. Boyd developed the NTI therapeutic protocol to rid him of his pain. He is now an associate with The Headache Center Neurology Clinic in Encinitas, Calif.

    National Dentex owned Keller Laboratory has been the exclusive U.S. manufacturer of the NTI-tss for the past six years. During that time unit sales of the appliance have grown at an average annual rate of more than 30%.

    David Brown, president & CEO, commented: "We believe the NTI to be an exceptional health care product. Our agreement with Dr. Boyd not only enables us to continue to support and provide relief to people who suffer from debilitating migraines, but to expand that support throughout our entire laboratory system of 47 locations across the United States."

    For more information, go to National Dentex Corporation.

    To read more about National Dentex Corporation, go to National Dentex Corporation.

    To comment on this subject, go to PennWell Dental Community site.